Galectin Therapeutics stock surges on FDA trial agreement
Galectin Therapeutics stock surges on FDA trial agreement
Galectin Therapeutics stock surges on FDA trial agreement
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.